Safety and immunogenicity of an anti-hepatitis-B vaccine obtained using the recombinant DNA technique: results of a longitudinal study in hospital personnel;Sicurezza ed immunogenicità di un vaccino anti-epatite B ottenuto con la tecnica del DNA-ricombinante: risultati di un'indagine longitudinale su personale ospedaliero.

Bollettino dell'Istituto sieroterapico milanese

Volumn 69, Issue 2, 1990, Pages 385-390

  Ricciardi, G ^a   Graziano, G ^a  

^a UNIVERSITY OF CASSINO AND SOUTHERN LAZIO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ENGERIX-B; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE; RECOMBINANT VACCINE;

ADULT; ARTICLE; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL; HEPATITIS B; HOSPITAL PERSONNEL; HUMAN; IMMUNIZATION; IMMUNOLOGY; ITALY; MIDDLE AGED; OCCUPATIONAL DISEASE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; ITALY; MIDDLE AGED; OCCUPATIONAL DISEASES; PERSONNEL, HOSPITAL; PROSPECTIVE STUDIES; VACCINES, SYNTHETIC;

EID: 0025443860     PISSN: 00212547     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)